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FIG. 1. Comparison of NSAID action on human GAG synthesis showing individual numbers of patients responding. The
data is expressed as a % of those patients showing a significant (P<0.01) increase or decrease in GAG synthesis in the
population undergoing the specific NSAID treatment. The concentration range of NSAIDs tested is shown. Figures in
brackets indicate the number of patients’ cartilages tested (TPA=tiaprofenic acid).HUMAN articular cartilage is continually
remodelled both during growth and development
and during adult life. This remodelling involves
both the synthesis and turnover of the principal
extra-cellular matrix macromolecules, the glyco-
saminoglycan (GAG) turning over several times as
rapidly as the fibrillar collagen. Normal synthesis
and breakdown of these molecules is mediated by
the indigenous chondrocytes. Changes in meta-
bolic activity of these cells has been postulated to
be a factor in the development of cartilage lesions
characteristic of osteoarthritis. If the synthesis of
extra-cellular matrix is reduced this will eventu-
ally lead to deterioration of the physical properties
of the matrix and expedite the changes character-
istic of OA. Conversely the ability to resynthesize
matrix confers the potentiality for repair and313regeneration. Even in severe OA, human articular
chondrocytes retain the ability to synthesize new
matrix components although sometimes only a
minority of chondrocytes demonstrate this
function.
Clinicians have commented on the possibility of
joint healing over many years, thus Perry and
co-workers [1] reported on 14 patients in whom
joint recovery showed radiographically for a
period of ten years after the original diagnosis,
whilst Danielsson [2], in a series of 91 patients,
also showed an apparent regression of arthritic
changes in a proportion of the cases.
It has been suggested that in OA the local
release of cytokines, and in particular IL-1, may
be an episodic process, perhaps due to micro-
inflammation of local mechanical trauma. Human
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sensitive to inhibition by sub-nanogram concen-
trations of IL-1. The inhibitory action of IL-1 may
be important in preventing the natural repair
mechanisms that can take place. If this is the case
it is important to consider how control of such
cytokine action can be modulated by drug inter-
vention, and even more important to ensure that
the therapy itself does not add to the problem.
Since at present there are no quantitative non-
invasive methods for determining the anabolic and
catabolic activity of NSAIDs on human cartilage
in vivo, most information on the role of cytokines
and drugs has come from short-term organ culture
studies. In the present work the relative GAG
synthetic activity of 80 non-arthritic (N) and 245
OA human cartilage was investigated using a
standardized short-term organ culture technique
(Fig. 1). This method was also used to study the
in-vitro e#ect of 11 NSAIDs on more than 150
patients’ cartilage. Consideration of results from
the present study and published material [3] lead
to the suggestion that NSAIDs may be divided into
three categories, with respect to their in-vitro
action on human OA cartilage: (1) those such as
aceclofenac, tenidap and tolmetin, which can
stimulate GAG synthesis; (2) those such as piroxi-
cam, tiaprofenic acid and aspirin, which are with-
out a significant e#ect on GAG synthesis in apopulation; and (3) those like naproxen, ibuprofen
and indomethacin, which significantly inhibit
GAG synthesis.
Whilst the inhibitory e#ect of certain NSAIDs
can be explained in terms of cytotoxic e#ects
on chondrocyte metabolism of the compounds or
their metabolites, the stimulatory action of other
NSAIDs at plasma concentrations is due to reduc-
tion of IL-1 activity and consequent expression of
growth factor activity. Other NSAIDs that may
also inhibit IL-1 synthesis or release probably do
not have a marked e#ect as they have toxic e#ects
on cartilage metabolism.
Caution must be exercised in extrapolation
from in-vitro to in-vivo e#ects of NSAID’s but it
seems possible that some highly e#ective anti-
inflammatory agents may have adverse e#ects on
cartilage integrity when employed during long-
term treatment. This possibility is supported by
limited in-vivo work.References
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